AAAAAA

   
Results: 1-8 |
Results: 8

Authors: Pinto, DJP Orwat, MJ Wang, SG Fevig, JM Quan, ML Amparo, E Cacciola, J Rossi, KA Alexander, RS Smallwood, AM Luettgen, JM Liang, L Aungst, BJ Wright, MR Knabb, RM Wong, PC Wexler, RR Lam, PYS
Citation: Djp. Pinto et al., Discovery of 1-[3-(aminomethyl)phenyl]-N-[3-fluoro-2 '- (methylsulfonyl)-[1,1 '-biphenyl]-4-yl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide (DPC423), a highly potent, selective, and orally bioavailable inhibitor of blood coagulation factor Xa, J MED CHEM, 44(4), 2001, pp. 566-578

Authors: Galemmo, RA Wells, BL Rossi, KA Alexander, RS Dominguez, C Maduskuie, TP Stouten, PFW Wright, MR Aungst, BJ Wong, PC Knabb, RM Wexler, RR
Citation: Ra. Galemmo et al., The de novo design and synthesis of cyclic urea inhibitors of factor Xa: Optimization of the S4 ligand, BIOORG MED, 10(3), 2000, pp. 301-304

Authors: Nakayama, A Saitoh, H Oda, M Takada, M Aungst, BJ
Citation: A. Nakayama et al., Region-dependent disappearance of vinblastine in rat small intestine and characterization of its P-glycoprotein-mediated efflux system, EUR J PH SC, 11(4), 2000, pp. 317-324

Authors: Aungst, BJ Nguyen, NH Bulgarelli, JP Oates-Lenz, K
Citation: Bj. Aungst et al., The influence of donor and reservoir additives on Caco-2 permeability and secretory transport of HIV protease inhibitors and other lipophilic compounds, PHARM RES, 17(10), 2000, pp. 1175-1180

Authors: Aungst, BJ
Citation: Bj. Aungst, Intestinal permeation enhancers, J PHARM SCI, 89(4), 2000, pp. 429-442

Authors: Aungst, BJ
Citation: Bj. Aungst, The influence of fatty acids and fatty alcohols on skin permeability, CRC DERMAT, 2000, pp. 299-309

Authors: Saitoh, H Aungst, BJ
Citation: H. Saitoh et Bj. Aungst, Improvement of the intestinal absorption of a peptidomimetic, boronic acidthrombin inhibitor possibly utilizing the oligopeptide transporter, PHARM RES, 16(11), 1999, pp. 1786-1789

Authors: Aungst, BJ
Citation: Bj. Aungst, P-glycoprotein, secretory transport, and other barriers to the oral delivery of anti-HIV drugs, ADV DRUG DE, 39(1-3), 1999, pp. 105-116
Risultati: 1-8 |